Compare BLD & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLD | DVA |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | 14707 | N/A |
| Industry | Engineering & Construction | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 10.1B |
| IPO Year | 2015 | 2002 |
| Metric | BLD | DVA |
|---|---|---|
| Price | $347.99 | $154.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | ★ $439.57 | $156.75 |
| AVG Volume (30 Days) | 343.1K | ★ 730.0K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 18.28 | 9.84 |
| Revenue | $2,384,249,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $13.44 | $3.85 |
| Revenue Next Year | $4.30 | $3.07 |
| P/E Ratio | $19.00 | ★ $15.90 |
| Revenue Growth | ★ 25.07 | 6.46 |
| 52 Week Low | $272.24 | $101.00 |
| 52 Week High | $559.47 | $159.42 |
| Indicator | BLD | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 28.31 | 59.71 |
| Support Level | $331.33 | $146.05 |
| Resistance Level | $445.50 | $158.31 |
| Average True Range (ATR) | 13.56 | 3.81 |
| MACD | 1.05 | -0.46 |
| Stochastic Oscillator | 26.58 | 75.16 |
TopBuild Corp is an installer and distributor of insulation products. Its operating segments are: Installation Services and Specialty Distribution. The Installation Services segment, which generates maximum revenue, installs insulation, commercial roofing, and other building products like glass and windows, rain gutters, doors, etc, mainly in the residential new construction market. The Specialty Distribution segment distributes building and mechanical insulation, insulation accessories, and other building product materials for the residential, commercial, and industrial markets. In addition to insulation and accessories, it distributes rain gutters, closet shelving, roofing materials, and other items. Geographically, the firm mainly operates in the U.S. and, to a lesser extent, in Canada.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.